13D/13G Filings - InvaGen Pharmaceuticals Inc.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-10-19
07:26 am
Sale
2022-10-1113DAvenue Therapeutics, Inc.
ATXI
InvaGen Pharmaceuticals Inc.0
0.000%
-9,476decrease
(Position Closed)
Filing
History
2022-07-28
4:30 pm
Purchase
2022-07-2513DAvenue Therapeutics, Inc.
ATXI
InvaGen Pharmaceuticals Inc.9,476
46.950%
533increase
(+5.96%)
Filing
History